INTRODUCTION
Plasmalogens are a subclass of glycerophospholipids that are characterized by a vinyl-ether bond at the sn-1 position of the glycerol backbone. It has been suggested that serum plasmalogen levels are associated with diverse clinical manifestations 1 . Recently, particular attention has been paid to the involvement of plasmalogens in metabolic diseases associated with oxidative stress and chronic inflammation 2 6 . Some studies have postulated that plasmalo-place exclusively in peroxisomes, with some patients with peroxisomal disorders exhibiting a systemic reduction in plasmalogens. It has recently been reported that plasmalogen synthesis is controlled by posttranslational regulation of fatty acyl-CoA reductase 1 Far1 , which converts a fatty acyl-CoA into a fatty alcohol in the peroxisome, subsequently introducing a fatty alcohol to the glycerol backbone at the sn-1 position as an alkenyl chain 10 . Although the origin of fatty acyl-CoA, which is a substrate for Far1, is still unknown, it is possibly derived from the synthesis of acetyl CoA from the peroxisomal beta-oxidation of VLCFAs such as lignoceric acid C24:0 11 . If so, VLCFAs and peroxisome proliferator-activated receptor-alpha PPARα agonists may contribute to increased serum plasmalogens by supplying materials for plasmalogen biosynthesis and activating peroxisomal beta-oxidation, respectively. Several studies suggest a link between peroxisomal beta-oxidation of VLCFAs and plasmalogen biosynthesis 12, 13 . In particular, nervonic acid C24:1 is beta-oxidized preferentially in peroxisomes 14 , and is abundant in brain myelin, where high levels of plasmalogens are also found 1 .
On the other hand, accumulation of saturated VLCFAs such as hexacosanoic acid C26:0 in plasma, which probably results from dysfunctional peroxisomal beta-oxidation, is considered to be a predisposing factor and diagnostic marker for peroxisomal disorders 15 . Furthermore, the evidence suggests that peroxisomal dysfunction is associated not only with rare peroxisomal disorders, but also with more common age-related diseases including neurodegenerative disorders such as Alzheimer s disease 16 , as well as metabolic diseases related to oxidative stress and chronic inflammation 17, 18 . Thus, elevated plasma-saturated VLCFAs seem to be an indication of peroxisomal dysfunction as well as a symptom of age-related diseases 19, 20 .
These contradictory findings led us to investigate the relationship between the serum levels of saturated and monounsaturated VLCFAs, clinical and biochemical parameters, and serum levels of plasmalogens. The study was performed in Japanese asymptomatic males aged over 40 years with MetS n 117 . Fatty acids in serum lipids were quantified using GC/MS. Serum plasmalogen levels were determined by liquid chromatography using radioactive iodine 125 I-HPLC , and the molecular composition of serum plasmalogen was analyzed by LC/MS/MS. We found that the proportions of saturated and monounsaturated VLCFAs such as nervonic acid in serum lipids were associated with serum levels of plasmalogens and with MetS, which suggests an involvement in the peroxisomal dysfunction and enhancement of ER stress seen in common age-related diseases.
MATERIALS & METHODS

Study subjects and design
Asymptomatic male subjects n 117; age, 40-66 years old not on medication who were referred for routine health examinations were enrolled in the study. Written informed consent was obtained from all participants, and the studies were approved by the ethics committees of Hokkaido University, Teikyo University School of Medicine, and ADEKA Co., Ltd. Sera were separated from fasting blood in the blood collection tube containing coagulation accelerating agent by centrifugation at 1,500 g for 10 min, and were added with BHT final concentration of 10 μM and EDTA final concentration of 1 mM as antioxidants, followed by immediate freezing at 80 until analysis. Measurements of body weight, stature, waist circumference, and blood pressure were recorded.
Sample preparation for quanti cation of fatty acids in
serum lipids Lipid samples were prepared using a slightly modified direct transesterification method described by Lepage & Roy 21 . In brief, tridecanoic acid C13:0 as an internal standard, dissolved in 1 mL of methanol/benzene 3:2, by vol , was added to an aliquot of 100 μL of serum. One milliliter of freshly prepared acetyl chloride/methanol 5:100, by vol was then added to each tube, which was capped and subjected to methanolysis at 100 for 2 h. After cooling the tube to room temperature, 1 mL of hexane and 1 mL of water were added. The tubes were then shaken, centrifuged, and the hexane layer harvested. This procedure was repeated three times, and the hexane layer collected was stored at 4 until analysis.
GC/MS analysis
Gas chromatography/mass spectrometry was conducted according to a slightly modified procedure described by Takemoto et al. 22 . In brief, methylated samples were subjected to a GC/MS system GC; Agilent 7890A, MSD; Agilent 7975C, Tokyo, Japan with a capillary INNOWAX column 30 m, 0.25 mm, Hewlett-Packard, Palo Alto, CA, USA . The initial oven temperature was 100 , which was increased to 240 15 /min and maintained for 15 min. One microliter of sample was injected into the GC/MS system in the splitless mode. Electron impact EI ionization was applied at 70 eV. Mass spectrometry acquisition of each substance was set to the selected-ion monitoring SIM mode. Intraassay n 10 CV using C13:0, palmitic acid C16:0 , oleic acid C18:1 , arachidonic acid C20:4 , and C24:1 ranged from 1.2 to 6.1 .
Measurement of serum plasmalogen levels
Serum plasmalogen concentrations were determined by our original method using radioactive iodine 125 2.5 Determination of molecular composition of serum plasmalogens Total serum lipids were extracted using chloroform/ methanol 1:2, by vol . Plasmalogens in the extracted lipids were analyzed by LC/MS/MS. Synthetic 18:0-18:1, 18:0-20:4, and 18:0-22:6 of each choline plasmalogen PlsCho and ethanolamine plasmalogen PlsEtn; Avanti Polar Lipids, Inc., Alabaster, AL, USA were used not only to generate a standard curve to quantify individual molecular species of plasmalogen, but also to assess the precision and accuracy of detection, as described previously 25 . The concentrations of individual molecular species of plasmalogens were determined using corresponding internal standards 1,2-dimyristoyl phosphatidylcholine; DMPC for PlsCho and 1,2-dimyristoyl phosphatidylethanolamine; DMPE for PlsEtn; Avanti Polar Lipids . The mean recovery of 18:0-18:1 and 18:0-20:4 of each PlsCho and PlsEtn, as well as DMPC, was 91.8 . Intra-assay n 10 coefficient of variation percentage CV of these phospholipids ranged from 5.1 to 8.5 .Twenty-nine molecular species were recorded for each class of plasmalogen, all of which were major molecules determined by LC/MS/MS.
LC/MS/MS analysis
Liquid chromatography-tandem mass spectrometry was conducted following a slightly modified method described previously 26 . Liquid chromatography separation was performed using an Accela UPLC system Thermo Fisher Scientific Inc., Waltham, MA, USA with a BEH C8 column 1.7 μm, 100 mm 2.1 mm i.d.; Waters Corp., Milford, MA, USA at 60 and a flow rate of 450 μL/min. Mobile phase A consisted of water containing 5 mM ammonium formate, while mobile phase B consisted of acetonitrile. Mobile phase A was set at 80 at 0 min, decreased linearly to 20 at 1.5 min, to 10 at 18 min, then to 5 at 20 min, and maintained at 5 for 1 min before being returned to starting conditions. The MS analysis was performed using a TSQ Quantum Access Max Thermo Fisher Scientific Inc. equipped with an HESI probe in positive ion mode. The MS operating conditions were optimized as follows: spray voltage of 3,000 V, and the capillary and vaporizer temperatures, 250 and 500 respectively. Nitrogen was used as both the sheath and auxiliary gas. Argon was used as the collision gas at a pressure of approximately 1.0 mtorr. The collision energy was 32 eV for PlsCho, and 20 eV for PlsEtn. Data acquisition was performed with Xcalibur 1.3 software Thermo Fisher Scientific Inc. . PlsEtn was quantified according to the procedure described by Zemski & Murphy 27 . In brief, fragment ions at m/z 364, 391, and 392
were used for the identification of the sn-1 position of PlsEtn containing hexadecanol 16:0 , octadecanol 18:0 , and octadecenol 18:1 , respectively. Choline plasmalogens identified by three characteristic fragments precursor 184 derived from phosphocholine, as well as sn-1 origin and sn-2 origin fragments were quantified using a fragment ion at m/z 184, following the separation of each molecule species by UPLC 28 . The presence of plasmalogens was further confirmed by the disappearance of the peak upon treatment with acid by exposing to HCL vapor for 10 min.
Biochemical analysis
Serum concentrations of triglyceride TG , high density lipoprotein cholesterol HDL-C , low density lipoprotein cholesterol LDL-C , total phospholipids PL , blood glucose, uric acid UA , aspartate aminotransferase AST , alanine aminotransferase ALT , and gamma-glutamyl transpeptidase γ-GTP were determined enzymatically with an AutoAnalyzer JCA-BM8060; JEOL, Ltd, Tokyo, Japan and reagent kits Wako Pure Chemical Industries, Ltd, Osaka, Japan . Small dense low density lipoprotein cholesterol sdLDL-C was measured using the sdLDL-EX Seiken Kit Denka Seiken, Tokyo, Japan . High-sensitivity C-reactive protein hsCRP was quantified by a latex photometric immunoassay LPIA ACE CRP-H II; Mitsubishi Chemical Medience Corp . Homocysteine Hcy was measured enzymatically using the Alfresa Auto Hcy Kit Alfresa Pharma Corp., Osaka, Japan . Total adiponectin was determined using a sandwich ELISA system Adiponectin ELISA Kit; Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan .
Statistical analysis
Statistical analysis was performed using Excel 2010; Microsoft Corporation, Redmond, WA with the add-in software Statcel 3 OMS, Tokyo, Japan . All values are shown as mean SD. Results were analyzed by unpaired t-test Fig. 1, Tables 1 and 3 . Correlations among measurements were assessed with Pearson s product-moment correlation coefficient Table 5 . The significance of differences between non-MetS and MetS subjects was evaluated by an unpaired t-test (*p < 0.05, **p<0.01, ***p<0.001). ΣSFA; sum of all saturated fatty acids, ΣMUFA; sum of all monounsaturated fatty acids, ΣPUFA n6; sum of all n-6 series of polyunsaturated fatty acids, ΣPUFA n3; sum of all n-3 series of polyunsaturated fatty acids.
RESULTS
Characteristics of study subjects
Clinical parameters and serum biochemical measurements of the subjects are shown in Table 1 according to the presence or absence of MetS non-MetS; n 102, MetS; n 15 . The data indicate that there were significant differences in various clinical and biochemical parameters between non-MetS and MetS, including weight, body mass index BMI , waist circumference, systolic s.p. and diastolic blood pressure d.p. , blood glucose, serum levels of γ-GTP, HDL-C, LDL-C, sdLDL-C, TG, hsCRP, as well as adiponectin.
Fatty acids in serum lipids
The concentration μM and composition mol of fatty acids in serum lipids for the study subjects male, average age 47.9 6.3, n 117 are shown in Table 2 . A large fraction of the fatty acids were higher than the upper limit of the reference values provided male; n 125, aged 21-64 years; female; n 132, aged 21-64 years; SRL Inc. . High values which exceeded reference data in the study may be due to the influences of gender and age. Eicosapentaenoic acid EPA, C20:5 on the other hand showed values 1/5-1/50 less than the reference value. The large difference in C20:5 values may be due to the low separation of C20:5 from C20:4 in gas chromatography Table 2 .
Significant differences in variable fatty acids were shown between non-MetS and MetS Fig. 1 . In addition to linoleic acid C18:2 and C20:4 among the polyunsaturated fatty acids PUFAs , the compositions mol of particular saturated and monounsaturated VLCFAs such as C22:0, C24:0 and C24:1 were significantly reduced in MetS compared to non-MetS subjects Fig. 1 .
Serum plasmalogens
Serum concentrations of each class of plasmalogens, i.e., PlsCho and PlsEtn, as well as PL, along with the class ratio PlsCho/PlsEtn and their proportions mol in total phospholipids PlsCho/PL, PlsEtn/PL , are summarized for non-MetS and MetS subjects in Table 3 . Compared to nonMetS subjects, MetS subjects showed significantly lower levels of PlsCho and higher levels of PL, with a resultant decline in the PlsCho/PlsEtn, PlsCho/PL, and PlsEtn/PL ratios. The molecular composition of each class of plasmalogens is shown in Table 4 . In the long-chain fatty alcohol species in the sn-1 position of plasmalogens, hexadecanol 16:0 was the predominant fatty alcohol species in PlsCho, whereas three alcohol species were distributed almost equally in PlsEtn. Arachidonic acid, the major fatty acid in the sn-2 position, was common in both classes of plasmalogens. In addition, docosahexaenoic acid DHA; C22:6 levels were high in PlsEtn, and C18:2 was specifically abundant in PlsCho.
3.4
Relationship between specific saturated and monounsaturated VLCFAs and biochemical and plasmalogen-related parameters We found that the proportions of specific saturated and monounsaturated VLCFAs such as C22:0, C24:0 and C24:1, as well as C20:4, in serum lipids were strongly associated with lipid-related risk factors for atherogenic status, i.e., HDL-C, TG and sdLDL-C Fig. 2 . These fatty acids correlated positively with serum levels of HDL-C, and inversely with serum levels of TG and sdLDL-C.
The interrelationship among these fatty acids and the relationship between fatty acids and plasmalogen-related parameters is shown in Table 5 . In particular, these VLCFAs indicated strong associations, suggesting that they are metabolized through an identical pathway. In addition, these saturated and monounsaturated VLCFAs, especially C24:1, as well as C20:4, showed a significant positive corre- Values show means SD * refferences data from SRL Inc.
lation with plasmalogen-related parameters, i.e., the serum levels of PlsCho and PlsEtn, and the proportions of PlsCho PlsCho/PL or total plasmalogens in total phospholipids PlsCho PlsEtn /PL Table 5 .
DISCUSSION
The proportion of subjects with MetS in the present study 12.8 was unexpectedly low when compared with that of the Japanese middle-aged male population [20] [21] [22] [23] [24] [25] , and was probably due to the exclusion of subjects taking medications such as hypoglycemic, hypotensive, or hypolipidemic drugs.
We found that MetS subjects showed a significant reduction in the proportions of specific saturated and monounsaturated VLCFAs such as C22:0, C24:0 and C24:1, as well as C18:2 and C20:4 in serum lipids compared to non-MetS subjects Fig. 1 . These VLCFAs as well as C20:4 were positively associated with serum levels of HDL-C, and inversely with serum levels of TG and sdLDL-C Fig. 2 . The results suggest that these VLCFAs are a potential indicator of MetS, because the dyslipidemia of MetS is characterized by the low level of HDL-C and high levels of TG and sdLDL 29 .
However, previous studies have reported that an increase in saturated VLCFAs such as C26:0 in red blood cells was associated with atherosclerosis and MetS 19, 20 . In the present study, although we could not quantify C26:0 in serum lipids of apparently healthy subjects as the concentrations were too low to detect, other saturated and monounsaturated VLCFAs showed different results to previous studies. Elevated plasma and tissue levels of both saturated increased elongation of chain length in fatty acids, in addition to reduced peroxisomal beta-oxidation activity 30 . The treatment of X-ALD patients with Lorenzo s oil 31 , which consists of supplements of C18:1 and erucic acid C22:1 , resulted not only in normalization of C26:0 levels, but also a significant increase in C24:1 30 , probably by competition for the microsomal elongation system 32 . Gene expression of Elovl3, a microsomal enzyme involved in VLCFA elongation, may be under the control of PPARα 33 , which is well known to regulate peroxisomal beta-oxidation. In patients with a deficiency in acyl-CoA oxidase Acox1 , the first and rate-limiting enzyme of the peroxisomal beta-oxidation pathway, plasma VLCFA is markedly elevated 15 . Interestingly, the restoration of ACOX1 expression in ACOX1-deficient mice strongly increased C24:1 levels 34 . These findings suggest that the peroxisome and ER act in concert to regulate plasma VLCFAs. Age-related diseases such as atherosclerosis and MetS lead to a decline in peroxisomal activity and enhance ER stress 35, 36 , causing a severe imbalance in the synthesis and degradation of VLCFAs, which may eventually result in increased C26:0 and decreased C24:1 in plasma, although the mechanism is unknown. Similarly to C22:0, C24:0 and C24:1, serum levels of PlsCho and the resultant PlsCho/PlsEtn and PlsCho/PL ratios of MetS subjects were significantly reduced compared to non-MetS subjects Table 3 . This result is in agreement with our previous study, in which hyperlipidemic subjects with MetS showed a considerable reduction in serum levels of both classes of plasmalogens compared to those without MetS 37 . In addition, these VLCFAs as well as C20:4 in serum lipids showed a significant positive correlation, particularly with PlsCho-related parameters Table 5 . As both classes of plasmalogens are rich in C20:4 Table 4 , it may be reasonable to suppose that there is a strong association between C20:4 and plasmalogen-related parameters. It is interesting to note that these VLCFAs, especially C24:1, are positively associated with plasmalogen-related parameters, despite the fact that plasmalogens are free from these VLCFAs Table 4 . In serum, these VLCFAs are largely contained in sphingolipids, the elevation of which is deemed to be a risk parameter for atherosclerosis 38 . However, these VLCFAs are minor components of sphingolipids. Interestingly, ingestion of edible oils which contain massive monounsaturated VLCFAs such as C22:1 and C24:1 resulted in significantly increased serum plasmalogens in rats 39 . However, until now, there have been no reports of direct evidence suggesting a link between plasmalogen biosynthesis and C24:1. Therefore the significant positive correlation of C24:1 in serum lipids with serum levels of plasmalogens may stem from decreased peroxisomal function and augmentation of ER stress, as plasmalogen biosynthesis involves both organelles 40 .
CONCLUSION
The proportion of nervonic acid C24:1 in serum lipids was associated with MetS and with levels of serum plasmalogens, especially PlsCho. This is probably a reflection of peroxisomal dysfunction and the enhancement of ER stress seen in common age-related diseases. 
